← Latest Filings
K

Kiselak Tomas

Open-market buys
6
$49.0M total
Open-market sells
3
$833.2M total
Tracking since
Oct 2025
Open-market buy — $7.6M
CRESCENT BIOPHARMA, INC. · Jul 16, 2026
Open-market buy — $12.4M
CRESCENT BIOPHARMA, INC. · Jul 16, 2026
Open-market trades from the last two years.
32,341 Stock Option (Right to Buy) in VRDN
Held indirectly (See Footnote) · as of 2026-07-01
Viridian Therapeutics, Inc.\DE
CIK 0001590750